NAMSW - NewAmsterdam Pharma Company N.V. Warrant
https://www.newamsterdampharma.com
Momentum: Bearish
Recent News
Powered by Alpha Vantage
No recent news found.
AI Tools
Key Metrics
Trend: Downtrend
Source: Snapshot
None
52W High
$16.75
52W Low
$5.45
MA Status:
50D: Below
200D: Below
Beta (~1 neutral, <0.9 lower risk)
-0.01
Valuation
As of 2025-06-30 (Overview)
Trailing P/E (<15 better)
N/A
Forward P/E (<15 better)
N/A
EV/EBITDA (<8 favorable)
N/A
EV/Revenue (<3 favorable)
N/A
P/S (TTM) (<3 favorable)
N/A
P/B (<3 favorable)
N/A
Ownership
Source: Overview
Insiders (1–5% typical)
0.00%
Institutions (25–75% balanced)
0.00%
Shares Outstanding
0
Float
54,895,000
Dividend Yield (2–6% sweet spot)
N/A
Ex‑Dividend Date
N/A
Income & Growth
Profitability: Weak
As of 2025-06-30 (Overview)
Revenue (TTM)
64,006,000
Gross Profit (TTM)
64,006,000
EPS (TTM)
N/A
Profit Margin (>10% good)
-2.59%
Operating Margin (TTM) (higher better)
-1.86%
ROE (TTM) (>15% strong)
-0.28%
EPS YoY (Quarterly) (>10% good)
N/A
Revenue YoY (Quarterly) (>8% good)
7.40
Momentum
Bearish momentumValue
0.6629
Previous
0.8050
Trend
Falling
Signal Cross
No cross
As of
Sep. 12, 2025